Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/445
Title: Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury.
Epworth Authors: Phillips, David
Other Authors: Chen, Yi
Rothnie, Christine
Spring, Denise
Verrier, Edward
Venardos, Kylie
Kaye, David
Hedger, Mark
Smith, Julian
Keywords: Epworth Research Institute, Epworth HealthCare, Richmond, Victoria, Australia
Heart
Ischemia
Reperfusion
Activin A
Follistatin
Myocardial Infarction
Hypoxia
Oxygen Deficiency
Deficiency, Oxygen
Myocytes, Cardiac
Cardiomyocytes
Muscle Cells, Cardiac
Toll-Like Receptors
Receptors, Toll-Like
Issue Date: Oct-2014
Publisher: Elsevier
Citation: Cytokine 2014 Oct;69(2):255-62
Abstract: Activin A, a member of the transforming growth factor-β superfamily, is stimulated early in inflammation via the Toll-like receptor (TLR) 4 signalling pathway, which is also activated in myocardial ischaemia-reperfusion. Neutralising activin A by treatment with the activin-binding protein, follistatin, reduces inflammation and mortality in several disease models. This study assesses the regulation of activin A and follistatin in a murine myocardial ischaemia-reperfusion model and determines whether exogenous follistatin treatment is protective against injury. Myocardial activin A and follistatin protein levels were elevated following 30 min of ischaemia and 2h of reperfusion in wild-type mice. Activin A, but not follistatin, gene expression was also up-regulated. Serum activin A did not change significantly, but serum follistatin decreased. These responses to ischaemia-reperfusion were absent in TLR4(-/-) mice. Pre-treatment with follistatin significantly reduced ischaemia-reperfusion induced myocardial infarction. In mouse neonatal cardiomyocyte cultures, activin A exacerbated, while follistatin reduced, cellular injury after 3h of hypoxia and 2h of re-oxygenation. Neither activin A nor follistatin affected hypoxia-reoxygenation induced reactive oxygen species production by these cells. However, activin A reduced cardiomyocyte mitochondrial membrane potential, and follistatin treatment ameliorated the effect of hypoxia-reoxygenation on cardiomyocyte mitochondrial membrane potential. Taken together, these data indicate that myocardial ischaemia-reperfusion, through activation of TLR4 signalling, stimulates local production of activin A, which damages cardiomyocytes independently of increased reactive oxygen species. Blocking activin action by exogenous follistatin reduces this damage.
URI: http://hdl.handle.net/11434/445
DOI: 10.1016/j.cyto.2014.06.017
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/25052838
ISSN: 1043-4666
Journal Title: Cytokine
Type: Journal Article
Affiliated Organisations: Department of Surgery, Monash Medical Centre, Monash University, Clayton, Victoria, Australia
MIMR-PHI Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia
Department of Surgery, School of Medicine, University of Washington, Seattle, WA, USA
Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
Department of Surgery, Monash Medical Centre, Monash University, Clayton, Victoria, Australia
Appears in Collections:Pre-Clinical

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.